TELA Bio (TELA) Return on Invested Capital (2025 - 2026)
TELA Bio's (TELA) quarterly Return on Invested Capital came in at 0.1% in Q1 2026, little changed quarter-over-quarter from 0.1% in Q4 2025.
TELA Bio (TELA) Return on Invested Capital (2025 - 2026) Analysis & Trends
TELA Bio's Return on Invested Capital history runs 2 years deep, the most recent figure standing at 0.1% for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.40 Bn | 176.11 Bn | 6.27 Bn | 0.01% |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn | 0.01% |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | 0.01% |
| 4 | Boston Scientific | 68.71 Bn | 67.25 Bn | 3.61 Bn | 0.00% |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn | 0.00% |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 0.00% |
| 10 | TELA Bio | 38.25 Mn | -1.29 Mn | 12.52 Mn | -0.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.10% |
| Dec 31, 2025 | -0.10% |